Bradley L. Radoff - 09 Dec 2025 Form 4 Insider Report for HARTE HANKS INC (HHS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Dec 2025, 17:53:16 UTC
Prior SEC filing
17 Nov 2025
Next SEC filing
12 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert Wyman, Attorney-in-fact for Bradley Radoff

Key filing fact

Bradley L. Radoff filed Form 4 for HARTE HANKS INC (HHS) on 11 Dec 2025.

Key facts

  • This page summarizes Bradley L. Radoff's Form 4 filing for HARTE HANKS INC (HHS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Dec 2025, 17:53.

Change

  • Previous filing in this sequence was filed on 17 Nov 2025.
  • Current net transaction value: +$89,991.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001380585 Primary reporting owner

Radoff Bradley Louis

Relationship
Director
Address
1 EXECUTIVE DR, SUITE 303, CHELMSFORD
Signature
/s/ Robert Wyman, Attorney-in-fact for Bradley Radoff
Signature date
11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock

Award

Transaction value
$89,991
Shares
+27,861
Change %
Price
$3.23
Shares after
27,861
Date
09 Dec 2025
Ownership
RSU shares held by Harte Hanks, granted to the participant but not yet vested
Footnotes
F1
HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
391,399
Date
09 Dec 2025
Ownership
Direct
HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,000
Date
09 Dec 2025
Ownership
Common stock held in participant's IRA
Footnotes
F2
HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,048
Date
09 Dec 2025
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

Footnote F2

Common stock held in participant's IRA

Footnote F3

Shares vested 100% on 5/23/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .